Eclipse Hypodermic Needle — Class II medical device recall Z-1440-2017
Terminated recall by Becton Dickinson & Company, reported 2017-03-22, distributed nationwide. BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering di
| Recall number | Z-1440-2017 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Becton Dickinson & Company, Franklin Lakes, NJ, United States |
| Recall initiated | 2016-12-20 |
| Classified | 2017-03-10 |
| Reported by FDA | 2017-03-22 |
| Terminated | 2018-04-20 |
| Distributed | Nationwide (US) |
| Quantity | 263 mm |
Product
Eclipse Hypodermic Needle
Reason for recall
BD is initiating a Product Advisory for the Eclipse Hypodermic Needle because of safety complaints covering disengagement and needlestick injuries.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1440-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.